A bioequivalence study of two telmisartan 80 mg tablets in healthy Indonesian subjects: an open label, three-way, three-period, partial replicate crossover study-Reference-Cited by-同舟云学术

A bioequivalence study of two telmisartan 80 mg tablets in healthy Indonesian subjects: an open label, three-way, three-period, partial replicate crossover study

Published:2020-10-02 Issue:11 Volume:46 Page:1747-1752
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Paramanindita Asti Swari¹^ORCID,Harahap Yahdiana²,Prasaja Budi¹,Wijayanti Tri Rahayu¹,Lusthom Windy¹,Sofiah Raden Efi¹,Sandra Monika¹,Trisari Yunia³

Affiliation:

1. P.T. Clinisindo Laboratories, Jakarta, Indonesia

2. Faculty of Pharmacy, University of Indonesia, Depok, Indonesia

3. P.T. Novell Pharmaceutical Laboratories, Jakarta, Indonesia

Funder

P.T. Novell Pharmaceutical Laboratories, Jakarta, Indonesia

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2020.1820042

Reference20 articles.

1. Telmisartan

2. Telmisartan: a review of its pharmacodynamic and pharmacokinetic properties

3. Comparative Effects of Telmisartan in the Treatment of Hypertension

4. College ter Beoordeling van Geneesmiddelen (CBG). Public assessment report of the medicines evaluation board in the Netherlands: Telmisartan Torrent 20 mg, 40 mg, 80 mg tablets Torrent Pharma GmbH, Germany. Netherlands: Medicines Evaluation Board; 2012 (report number: RVG 110355–110357).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and Bioequivalence of Fixed‐Dose Combination of Simvastatin and Ezetimibe Tablets: A Randomized, Crossover, Open‐Label Study in Healthy Volunteers;Clinical Pharmacology in Drug Development;2024-05-15

2. Pharmacokinetic and bioequivalence study of Telzap® Plus fixed-dose combination compared with MikardisPlus® in healthy volunteers after single administration;Pharmacokinetics and Pharmacodynamics;2023-01-19

3. Pharmacokinetic and Bioequivalence Study of Telzap AM® (Telmisartan/amlodipine Fixed-dose Combination) and Coadministered Mikardis® (Telmisartan) and Norvask® (Amlodipine) in Healthy Subjects;Drug development & registration;2020-11-26